- Home
- MOGO vs CNTB Comparison
MOGO vs CNTB Comparison
Compare MOGO & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- CNTB
- Stock Information
- Founded
- MOGO 2003
- CNTB 2012
- Country
- MOGO Canada
- CNTB United States
- Employees
- MOGO N/A
- CNTB N/A
- Industry
- MOGO
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- MOGO
- CNTB Health Care
- Exchange
- MOGO Nasdaq
- CNTB Nasdaq
- Market Cap
- MOGO 48.6M
- CNTB 54.4M
- IPO Year
- MOGO N/A
- CNTB 2021
- Fundamental
- Price
- MOGO $1.91
- CNTB $1.88
- Analyst Decision
- MOGO Strong Buy
- CNTB Strong Buy
- Analyst Count
- MOGO 1
- CNTB 2
- Target Price
- MOGO $4.00
- CNTB $7.50
- AVG Volume (30 Days)
- MOGO 283.1K
- CNTB 159.5K
- Earning Date
- MOGO 08-07-2025
- CNTB 08-13-2025
- Dividend Yield
- MOGO N/A
- CNTB N/A
- EPS Growth
- MOGO N/A
- CNTB N/A
- EPS
- MOGO 0.12
- CNTB N/A
- Revenue
- MOGO $30,265,570.00
- CNTB $1,965,000.00
- Revenue This Year
- MOGO $59.64
- CNTB N/A
- Revenue Next Year
- MOGO $5.55
- CNTB N/A
- P/E Ratio
- MOGO $14.83
- CNTB N/A
- Revenue Growth
- MOGO 0.18
- CNTB N/A
- 52 Week Low
- MOGO $0.74
- CNTB $0.51
- 52 Week High
- MOGO $3.83
- CNTB $2.86
- Technical
- Relative Strength Index (RSI)
- MOGO 57.06
- CNTB 50.32
- Support Level
- MOGO $1.63
- CNTB $1.60
- Resistance Level
- MOGO $1.81
- CNTB $1.86
- Average True Range (ATR)
- MOGO 0.09
- CNTB 0.24
- MACD
- MOGO 0.01
- CNTB -0.07
- Stochastic Oscillator
- MOGO 97.80
- CNTB 33.72
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.